Učitavanje...
The combination of neoantigen quality and T lymphocyte infiltrates identifies glioblastomas with the longest survival
Glioblastoma (GBM) is resistant to multimodality therapeutic approaches. A high burden of tumor-specific mutant peptides (neoantigens) correlates with better survival and response to immunotherapies in selected solid tumors but how neoantigens impact clinical outcome in GBM remains unclear. Here, we...
Spremljeno u:
| Izdano u: | Commun Biol |
|---|---|
| Glavni autori: | , , , , , , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Nature Publishing Group UK
2019
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6478916/ https://ncbi.nlm.nih.gov/pubmed/31044160 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s42003-019-0369-7 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|